Efficacy and safety of selective internal radiotherapy versus sorafenib for intermediate-locally advanced hepatocellular carcinoma: a systematic review and meta-analysis.

Jingwen ZouWeiliang ZhuHui MengPeng Luo Jian Zhang

Published in: Expert review of gastroenterology & hepatology (2019)

In patients with intermediate-locally advanced HCC, SIRT and SOR result in similar survival rates. The improved toxicity profile of SIRT may help when choosing between the two treatments.

Keyphrases

locally advanced
rectal cancer
oxidative stress
neoadjuvant chemotherapy
squamous cell carcinoma
radiation therapy
phase ii study
ischemia reperfusion injury
free survival
clinical trial
early stage